TB Elimination National Acceleration Programme
Theme: Infectious disease control
Reform at a glance
- What changes
- Accelerate tuberculosis prevention, diagnosis and treatment through expanded testing and access to care.
- Responsible actor (recorded)
- Department of Health / South African Medical Research Council / National Institute for Communicable Diseases
- Recorded status
- Partially implemented — editorial assessment.
- Milestone described by this status
- National End TB Plan 1.0 published for 2026/27.
- Next documented milestone
- Verify provincial testing, linkage to care and treatment outcomes against reported indicators.
Source review details
Agent-prepared claim inventory from committed snapshot; primary-source checks only where explicitly dated. Pending human review. Proposal summary prepared from the recorded reform scope on 2026-09-20; it makes no claim of implementation or quantified impact. Numerical impacts and implementation claims below remain provisional where the findings identify unresolved checks.
- A dated national TB plan is available. Publication does not verify programme delivery, current incidence or the record’s treatment-cost and productivity calculations; those require epidemiological and cost sources with denominators.
- Numerical or dated statements require source-by-source verification before reuse as established findings.
- Numerical or dated statements require source-by-source verification before reuse as established findings.
- Numerical or dated statements require source-by-source verification before reuse as established findings.
- Recorded status is partially_implemented. Scope of completion and present implementation have not been independently verified in this preparation.
- Recorded owner: Department of Health / South African Medical Research Council / National Institute for Communicable Diseases. Present allocation of responsibilities requires verification.
- Source recorded on idea; section not yet verified — source not yet verified
- End Tuberculosis Plan 1.0, April 2026–March 2027 — agent checked 2026-09-19
On this page
Description
South Africa has the world's highest absolute burden of tuberculosis, with approximately 300,000 new cases and 55,000 deaths annually, disproportionately affecting HIV-positive individuals and mineworkers. The TB Elimination Acceleration Programme targets a 90% reduction in TB incidence and mortality by 2030, aligned with the End TB Strategy. Key interventions include universal drug susceptibility testing, expanded access to bedaquiline-based regimens for drug-resistant TB, community-based active case finding, and workplace TB screening in mining. The Department of Health's TB Directorate coordinates with the National Health Laboratory Service (NHLS) and NGO partners. TB imposes a direct labour productivity cost — an estimated 0.5% of GDPGDP — Gross Domestic Product: The total monetary value of all goods and services produced within a country's borders in a given period. The primary measure of an economy's size and overall output. annually in lost working days and treatment costs. As of early 2026, TB incidence is declining but remains far above elimination thresholds; funding gaps at provincial health departments constrain programme scale-up.
Assessment
Responsible: Department of Health / South African Medical Research Council / National Institute for Communicable Diseases
Feasibility Assessment
Moderate feasibility. Proven implementation framework exists; progress is measurable. Key risk is the USAID funding withdrawal in 2025 creating drug supply and personnel gaps. MDR-TB requires sustained pharmaceutical procurement that is vulnerable to rand/dollar exchange rateExchange Rate: The value of one currency expressed in terms of another, determining the cost of international transactions. The rand exchange rate affects export competitiveness and import prices. volatility.
Where the numbers stand
All indicators →- Life Expectancy at Birth66.31 years2024
+0.86 years from 65.45 years in 2022, when this idea was first raised. World Bank / Stats SA (WDI SP.DYN.LE00.IN)
Series tagged to this idea’s binding constraint. The period beside each value is the latest observation this site holds, which can lag the official release: the series are rebuilt offline from the sources named, not read live. Most recent retrieval: 2026-09-13.
Stakeholder Landscape
Who backs this reform, who needs convincing, and which interests or red lines shape political feasibility.
Backers
10
1 stakeholder
Negotiation weight
0
0 conditional actors
Opposition weight
0
0 opposing actors
Coalition Read
AI-drafted stances · 0 reviewed
A coalition score needs at least 3 mapped stances, or actors carrying 25% of the map's influence. The stances below are the evidence; the average over this few of them would not be.
Anchor: Presidency / Operation Vulindlela.
Political Tractability
No reviewed signals · 0% of mapped influence has been reviewed.
TB elimination is a Presidential health priority given its direct impact on workforce productivity and health expenditure.
Interest: Cross-cutting structural reform coordination across energy, logistics, water, digital infrastructure, and visa reform. Operation Vulindlela, establish…
Concern: Implementation bottlenecks within line departments; regulatory capture of NERSA and ICASA; SOE institutional inertia; ensuring quick wins translate in…
Engagement path: Already fully engaged. Seeks line department buy-in, NEDLAC social compact legitimacy, and international DFI financing alignment on key reform milesto…
Referenced in OECD Economic Surveys: South Africa
OECD SA Survey (2017, 2020, 2022, 2025). Healthcare reform for better quality, access and efficiency is a key recommendation in the 2020 survey.
South Africa achieved its 2025 End TB milestone with a 57% reduction in incidence from 2015 — but 427 per 100,000 is still 40 times the elimination threshold; the programme must sustain progress without PEPFAR and USAID support. — National TB Recovery Plan 4.0, May 2025
International Comparisons
View all →Rwanda deployed 45,000 community health workers — two per village — to provide primary care to 12 million rural citizens from 2005. CHWs are elected by communities, receive three-month training, carry a drug supply kit, and are paid for performance-linked outcomes (vaccination rates, malnutrition screening). Child mortality fell from 196 per 1,000 live births (2000) to 45 (2020). Programme cost: USD 2 per capita annually. SA has 67,000 community health workers deployed inconsistently; Rwanda's structured incentive, training, and supply-chain system demonstrates the gap between programme ambition and delivery architecture.
Approach
Rwanda staffed every village with a small fixed team of community health workers chosen by the village itself, which is what produced the acceptance rates that later mattered for case-finding. They were trained to a defined scope — a fixed list of conditions they may screen, treat or refer — and given a replenished commodity kit supplied through the nearest health centre, which also supervised them. Payment was performance-based and made to a local community health worker cooperative rather than to individuals, so the incentive was collective. Reporting ran by mobile phone into a national system, giving supervisors near-real-time coverage data.
Timeline: National deployment from 2005; performance payment and mobile reporting layered on over the following five years; mortality gains over about 15 years
Lessons for South Africa
Community-based active case finding is the intervention SA's TB programme most depends on and least reliably delivers, and Rwanda shows this is a delivery-architecture problem rather than a headcount problem: SA already fields more community health workers than Rwanda does. What SA lacks is a defined scope of practice for TB screening and referral, a commodity kit and specimen-transport link to the NHLS that functions at village level, and payment tied to outcomes rather than attendance. Rwanda's near-real-time mobile reporting is also the missing feedback loop for a programme whose provincial funding gaps currently surface only in annual reports.
Evidence & Research
Research corpus →- Tuberculosis and co-existing common mental and substance-use disorders: a case for including mental healthcare and substance-use prevention as part of the tuberculosis treatment package in high-burden provinces
HSRC · Aug 2015
The paper analyses a specific problem affecting TB treatment outcomes in South Africa — the co-existence of mental health and substance-use disorders among TB patients — and argues for their inclusion in the TB treatment package, which directly bears on the design and effectiveness of the TB Elimin…
- Prevalence of psychological distress and associated factors in tuberculosis patients in public primary case clinics in South Africa
HSRC · Aug 2015
The paper studies psychological distress among TB patients in South Africa and identifies it as a barrier to treatment adherence and health outcomes, directly bearing on the health systems constraint and implementation challenges of the TB Elimination Acceleration Programme's goal to improve TB tre…
- CC2024/01 Buthelezi, T and Thibane, T. Strategic Patenting and its Impact on Competition: Evidence from the South African Pharmaceutical Sector
Competition Commission · Mar 2024
The paper analyses patent trends and strategic patenting behaviour in TB pharmaceuticals in South Africa, directly bearing on the policy's mechanism of expanding access to bedaquiline-based regimens and other TB drugs by examining how patent systems and competition law affect drug availability and…
Links proposed by lexical matching and screened by a calibrated research judge. Follow the paper for the full argument and its caveats.
Policy documents
No linked official-document evidence yet. Coverage is incomplete.
Parliamentary record
7 meetingsCommittee sittings this reform was drawn from, most recent first. Each row opens the meeting on this site; the PMG link goes to the source record.
Higher Education and Training
11 June 2025Briefing by Ingwe TVET College on governance, administration, teaching and learning and related matters
Health
16 May 2025Status of HIV/AIDs and TB Campaign in SA after PEPFAR withdrawal; with Minister
Health
17 October 2024Department of Health 2023/24 Annual Report; with Ministry
Health
10 July 2024Committee’s Budget Vote Report
Health
31 May 2023Tobacco Products and Electronic Delivery Systems Control Bill: Department briefing; Update on cholera outbreak; with Deputy Minister
Health
24 May 2023National Health Insurance (NHI) Bill: adoption; Cholera Outbreak; with Deputy Minister
Health
7 May 2021Department of Health 2021/22 Annual Performance Plan; with Deputy Minister
Get the Monday briefing by email
— A short weekly digest of what moved in SA policy.How to cite
Wilse-Samson, L. (n.d.). TB Elimination National Acceleration Programme. SA Policy Space. https://sa-policy-space.vercel.app/ideas/tb-elimination-national-acceleration-programme Live page. Data version: 2026-10-10.d2e346d2; data as of: 2026-10-10.
Status History
tracked since Mar 2026- Recorded as Partially implemented when status tracking began — held since at least Mar 2026.Mar 2026
Data as of 2026-10-10 · latest PMG meeting 2026-10-02